Vaccine stocks fall sharply after Trump names RFK Jr. as health secretary
Shares of vaccine companies dropped sharply on Thursday after President-elect Donald Trump selected Robert F. Kennedy Jr. as the next health secretary. Moderna fell 6%, Pfizer declined nearly 2%, and Novavax dropped almost 6%. Kennedy is known for promoting anti-vaccine views and has previously questioned vaccine safety. He stated he would study vaccine safety but would not remove vaccines from public access. Other vaccine-related stocks also suffered, with BioNTech down 7% and GSK falling 2%. Vaccine companies have faced declining demand since the pandemic's peak, impacting their stock performance over the past year.